Plant Health Care signs second major evaluation agreement for peptide platform

Plant Health Care recently signed its second agreement with an industry leader to evaluate its Innatus 3G peptide platform.

The Innatus platform technology allows for the design, screening and production of a large quantity of peptides with diverse bio-stimulant properties. The peptides can improve yields, promote pest and disease resistance, and protect against abiotic stress in a range of crops. Peptides also can complement existing practices by combining them with conventional crop protection chemicals in seed treatment and foliar applications.

Plant Health Care CEO Paul Schmidt said in just five months the company has achieved its 2015 goal of signing at least two evaluation agreements for the platform.

“We are targeting the largest players, and these agreements reflect the potential value they see in our platform,” Schmidt said. “Our dialogue with other major players is ongoing."

Schmidt did not identify specifically which company the second agreement was with. 

Organizations in this Story

Plant Health Care

Want to get notified whenever we write about Plant Health Care ?
Next time we write about Plant Health Care, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.